Department of General and Thoracic Surgery, University Hospital Virgen Macarena, Seville, Spain.
J Thorac Dis. 2010 Mar;2(1):29-35.
The application of video-assisted thoracic surgery (VATS) in major pulmonary resections is still far from routine in most hospitals, even though the safety and technical feasibility of the procedure have by now been amply demonstrated. This paper reports on the surgical technique used by the authors for VATS lobectomy, on their experience of the procedure and on the results obtained.
A retrospective study was performed of all patients undergoing VATS lobectomy at the our Thoracic Surgery Department ,between 1993 and 2009.The clinical records of all patients were reviewed, and the following variables were noted for purposes of analysis: patient age and sex; clinical diagnosis; staging; date of surgery; type of surgery; conversion to conventional surgery and grounds for conversion; duration of surgery; intraoperative, postoperative and long-term complications; postoperative stay, final diagnosis and staging; and death rates.
A total of 349 VATS lobectomies were performed over the study period (292 men, 57 women; mean age 59.7) The aetiology was non-small-cell lung carcinoma (NSCLC) in 313 patients and benign processes in 26;four patients had carcinoid tumours, and a further six required lobectomy due to metastases. The overall conversion rate was 9.4%. Mean duration of lobectomy was 148 minutes, and median duration 92 minutes. Mean postoperative was 3.9 days. The morbidity rate was 12.89 %, mostly involving minor complications. Perioperative mortality was 1.43%. There were no intraoperative deaths. The overall five-year survival rate for patients with NSCLC was 80.1%.
VATS lobectomy is a safe and technically-viable procedure that meets oncological criteria for lung-cancer surgery. Major pulmonary resection using VATS should be considered the procedure of choice for a number of benign processes and for early-stage bronchogenic carcinoma (T1-T2 N0 M0).
尽管视频辅助胸腔镜手术(VATS)在大多数医院的大肺切除中的应用仍远未普及,但该手术的安全性和技术可行性现在已经得到充分证明。本文报告了作者用于 VATS 肺叶切除术的手术技术、手术经验和获得的结果。
对我院胸外科 1993 年至 2009 年间行 VATS 肺叶切除术的所有患者进行回顾性研究。回顾所有患者的临床记录,并分析以下变量:患者年龄和性别;临床诊断;分期;手术日期;手术类型;转换为常规手术的原因和转换的原因;手术时间;术中、术后和长期并发症;术后住院时间;最终诊断和分期;死亡率。
在研究期间,共进行了 349 例 VATS 肺叶切除术(292 例男性,57 例女性;平均年龄 59.7 岁)。病因是 313 例非小细胞肺癌(NSCLC)和 26 例良性病变;4 例患者患有类癌肿瘤,另有 6 例因转移需要肺叶切除术。总体转换率为 9.4%。肺叶切除术的平均时间为 148 分钟,中位数为 92 分钟。平均术后住院时间为 3.9 天。发病率为 12.89%,主要为轻微并发症。围手术期死亡率为 1.43%。术中无死亡。NSCLC 患者的总体五年生存率为 80.1%。
VATS 肺叶切除术是一种安全且技术可行的手术方法,符合肺癌手术的肿瘤学标准。VATS 用于大的肺切除术应被视为治疗多种良性病变和早期支气管肺癌(T1-T2 N0 M0)的首选方法。